RetractionJ Nanopart Res2025
Retraction Note: Development of novel anti-Kv 11.1 antibody-conjugated PEG-TiO2 nanoparticles for targeting pancreatic ductal adenocarcinoma cells.
- Journal
- J Nanopart Res
- Published
- 27 February 2025
- Citations
- 0
- Type
- Retraction
- Retracted
- Yes
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try